Literature DB >> 26061852

Burden of Clostridium difficile infection in the United States.

Niaz Banaei, Victoria Anikst, Lee Frederick Schroeder.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26061852     DOI： 10.1056/NEJMc1505190

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Incidence and economic burden of Clostridioides difficile infection in Ontario: a retrospective population-based study.

Authors:  Jennifer A Pereira; Allison McGeer; Antigona Tomovici; Alex Selmani; Ayman Chit
Journal:  CMAJ Open       Date:  2020-01-30

2.  Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates.

Authors:  Cynthia Y Truong; Saurabh Gombar; Richard Wilson; Gopalakrishnan Sundararajan; Natasa Tekic; Marisa Holubar; John Shepard; Alexandra Madison; Lucy Tompkins; Neil Shah; Stan Deresinski; Lee F Schroeder; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2017-03-01       Impact factor: 5.948

3.  Toxin positivity and tcdB gene load in broad-spectrum Clostridium difficile infection.

Authors:  Hyeong Nyeon Kim; Hanah Kim; Hee-Won Moon; Mina Hur; Yeo-Min Yun
Journal:  Infection       Date:  2017-12-07       Impact factor: 3.553

4.  Identifying predictive features of Clostridium difficile infection recurrence before, during, and after primary antibiotic treatment.

Authors:  Sepideh Pakpour; Amit Bhanvadia; Roger Zhu; Abhimanyu Amarnani; Sean M Gibbons; Thomas Gurry; Eric J Alm; Laura A Martello
Journal:  Microbiome       Date:  2017-11-13       Impact factor: 14.650

5.  Risk factors and outcomes of Clostridium difficile infection in hospitalized patients.

Authors:  Hao-Yuan Lee; Hsuan-Ling Hsiao; Chin-Yuan Chia; Chun-Wen Cheng; Tzu-Cheng Tsai; Shin-Tarng Deng; Chyi-Liang Chen; Cheng-Hsun Chiu
Journal:  Biomed J       Date:  2019-05-07       Impact factor: 4.910

6.  Two-year analysis of Clostridium difficile ribotypes associated with increased severity.

Authors:  R Herbert; J Hatcher; E Jauneikaite; M Gharbi; S d'Arc; N Obaray; T Rickards; M Rebec; O Blandy; R Hope; A Thomas; K Bamford; A Jepson; S Sriskandan
Journal:  J Hosp Infect       Date:  2019-06-18       Impact factor: 3.926

7.  Fecal Microbiota Transplantation in Patients With Recurrent Clostridium difficile Infection: A Four-Year Single-Center Retrospective Review.

Authors:  Muhammad Farhan Ashraf; Omar Tageldin; Yousef Nassar; Asra Batool
Journal:  Gastroenterology Res       Date:  2021-07-28

8.  Laxative Use Does Not Preclude Diagnosis or Reduce Disease Severity in Clostridiodes difficile Infection.

Authors:  Nicole C White; Rafael Mendo-Lopez; Konstantinos Papamichael; Christine A Cuddemi; Caitlin Barrett; Kaitlyn Daugherty; Nira Pollock; Ciaran P Kelly; Carolyn D Alonso
Journal:  Clin Infect Dis       Date:  2020-09-12       Impact factor: 9.079

9.  Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes.

Authors:  Jennifer C Hunter; Yi Mu; Ghinwa K Dumyati; Monica M Farley; Lisa G Winston; Helen L Johnston; James I Meek; Rebecca Perlmutter; Stacy M Holzbauer; Zintars G Beldavs; Erin C Phipps; John R Dunn; Jessica A Cohen; Johannetsy Avillan; Nimalie D Stone; Dale N Gerding; L Clifford McDonald; Fernanda C Lessa
Journal:  Open Forum Infect Dis       Date:  2016-01-18       Impact factor: 3.835

10.  Incidence, risk factors, and outcome of Clostridioides difficile infection following urological surgeries.

Authors:  Kevin A Nguyen; Danny Q Le; Yvonne T Bui; Sonali D Advani; Joseph Renzulli; Patrick A Kenney; Michael S Leapman
Journal:  World J Urol       Date:  2021-01-20       Impact factor: 4.226
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.